A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IDUs / intravenous drug users

[Related PubMed/MEDLINE]
Total Number of Papers: 220
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IDUs  (>> Co-occurring Abbreviation)
Long Form:   intravenous drug users
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Complete genome sequencing and evolutionary analysis of HCV subtype 6xg from IDUs in Yunnan, China. HCV-6
2019 Effect of human pegivirus route of transmission on the genetic distribution of the virus: an institution based cross-sectional study. GBV-C, HPgV, MSM, RT-PCR
2019 Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis. HCV, IDU
2019 HIV prevention intervention for substance users: a review of the literature. NIDUs
2019 Prevalence and Risk Factors associated with Homelessness among Drug Users in Puerto Rico. ---
2019 Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection. AST/ALT, CI, HBV, HCV
2019 Surgery in drug use-associated infective endocarditis: long-term survival is negatively affected by recurrence. IE
2019 Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China. ART, NNRTI, NRTI, PDR, PI
2018 Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur. ADRMs, DRMs, HIV, NNRTIs, NRTIs, PIs, TDRMs
10  2018 Outcome of a hepatitis B vaccination program for clients of a drug consumption facility. DCF, HBV
11  2017 Assessment of HCV genotypes in Yunnan Province of Southwest China. GP, HCV
12  2017 CRF35-AD as the Main Circulating Genotype of Human Immunodeficiency Virus Type 1 Infection in Iran: A Phylogenetic and Demographic-Based Study. HIV-1
13  2017 Generation and Characterization of HIV-1 Transmitted and Founder Virus Consensus Sequence from Intravenous Drug Users in Xinjiang, China. HSX.CON, SGS
14  2017 Heroin use is associated with lower levels of restriction factors and type I interferon expression and facilitates HIV-1 replication. ---
15  2017 Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms. MTC, URFs
16  2017 Prevalence of Kaposi's sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis. CI, KSHV
17  2017 The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters. MSM, PR/RT
18  2017 [Evolutionary characteristics and positive selection site of hepatitis C virus isolated in intravenous drug users in Pudong new district, Shanghai]. DAA, HCV
19  2016 A Retrospective Review: Significance of Vegetation Size in Injection Drug Users with Right-Sided Infective Endocarditis. Pitt, RSIE
20  2016 HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area. ---
21  2016 Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. HTLV, IQR
22  2016 Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users. HCV
23  2016 Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. AOR, BCG, HIV, IGRAs, LTBI, QFT-G, QFT-GIT, TB, TST
24  2016 The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population. KIR, NK
25  2016 Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain. HTs, MSM, PI, PR/RT
26  2016 Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men. ACS, HBV, HBV-A, HBV-G, HBV-G, MSM
27  2016 [Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan]. MMT
28  2015 A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt? CS
29  2015 A SDF1 genetic variant confers resistance to HIV-1 infection in intravenous drug users in China. HESN, HESP, SNS, SS
30  2015 Deep neck infections in cervical injection drug users. DNI, SCM
31  2015 Deep vein thrombosis of the lower limbs in intravenous drug users. DVT
32  2015 Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest. ---
33  2015 Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. CRFs
34  2015 Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users. HESNs, IL-10
35  2015 Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics. DAAs, HCV, HIV-1
36  2015 Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. CIs, HIV, NSEP, ORs
37  2015 Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran. DICs, HCV, HIV
38  2015 The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China. HCV, NAT, NIDUs
39  2015 [Analysis on genotypes of hepatitis C virus among intravenous drug users in Kunming, Yunnan]. HCV, PCR
40  2014 A stochastic agent-based model of pathogen propagation in dynamic multi-relational social networks. ---
41  2014 Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users. HCV, TB
42  2014 Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers. ARV, ATT, NIDUs, PIMS
43  2014 Association of higher-risk alcohol consumption with injecting paraphernalia sharing behaviours in intravenous drug users. NICE
44  2014 Clinical classification and prognosis of isolated right-sided infective endocarditis. IE, RSIE
45  2014 Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. CI, DRDB, HCV, HETs, MSM, OR, SHCS
46  2014 Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran. ICER, MMT
47  2014 Early HIV diagnosis through use of rapid diagnosis test (RDT) in the community and direct link to HIV care: a pilot project for vulnerable populations in Athens, Greece. ART, EU, MSM, NSRF, PEP, RDT
48  2014 Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection. HESN
49  2014 Having Multiple Sexual Partners among Iranian Intra-Venous Drug Users. OR
50  2014 HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium. NNRTIs, NRTIs, PIs, SDRM
51  2014 Inability to detect human T cell lymphotropic virus type 2-specific antibodies in a patient coinfected with HIV-1, human T cell lymphotropic virus type 1, human T cell lymphotropic virus type 2, and hepatitis C virus. HCV
52  2014 Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden. DAAs, HCV, ML
53  2014 [Needle exchange programs are a cost-effective preventative measure against HIV in Iceland]. ICUR, NEPs, QALY
54  2013 Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. HESNs
55  2013 CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users. CCR5
56  2013 Death due to an unrecognized groin abscess in a drug addict: a retrospective study. ---
57  2013 Emerging variability in HIV-1 genetics among recently infected individuals in Yunnan, China. HIV-1
58  2013 Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users. HBV, HCV, SVR
59  2013 Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China. HBV, HCV
60  2013 Five new CRF07_BC near full-length sequences isolated from Sichuan, China. MCMC
61  2013 Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China. HCV
62  2013 HIV type 1 origin and transmission dynamics among different risk groups in sardinia: molecular epidemiology within the close boundaries of an Italian island. CRFs
63  2013 Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians. HTLV-2
64  2013 Prevalence of hepatitis C infection among intravenous drug users in Shanghai. HCV
65  2013 Projection of human immunodeficiency virus among high-risk groups in Malaysia. AIDS, HIV, MSM, STIs, SWs
66  2013 Protective effect of CCR5-Delta32 against HIV infection by the heterosexual mode of transmission in a Polish population. HCV, HIV
67  2013 Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region. HCV
68  2013 Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). aIRR, AOR, COHERE, LP
69  2013 Unprotected anal Intercourse among Iranian Intra-Venous Drug Users. CI, OR
70  2012 Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. HCV
71  2012 Clearance of an epidemic clone of methicillin-resistant Staphylococcus aureus in a drug-use network: a follow-up study in Switzerland. MRSA
72  2012 Clinical and laboratory characteristics of human immunodeficiency virus-infected adolescents: experience from a single medical center. AIDS, HAART, HIV, MSM, STD
73  2012 Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV. ART, miRNA, TI
74  2012 Estimation of the Frequency of Intravenous Drug Users in Hamadan City, Iran, Using the Capture-recapture Method. DICs, ORTs, VCTCs
75  2012 letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30. ---
76  2012 Modeling of human immunodeficiency virus modes of transmission in Iran. CI, MOT
77  2012 Molecular survey of hepatitis C virus in the touristic city of Mar del Plata, Argentina. HCV
78  2012 Parvovirus 4 infection and clinical outcome in high-risk populations. HCV, HIV, PARV4
79  2012 Phylogenetic analysis of the Latvian HIV-1 epidemic. FSU
80  2012 Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid (N)-based IgG ELISA assay for plasma samples from HIV-1 positive intravenous drug users (IDUs). IgG, IPTG, SARS-CoV
81  2012 Prevalence and knowledge of sexual transmitted infections, drug abuse, and AIDS among male inmates in a Taiwan prison. STIs
82  2012 Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. HCV, IVF
83  2012 [Characteristics of intravenous drug users who share injection equipment in Catalonia (Spain)]. ---
84  2012 [Distribution of HIV-1 subtypes among different populations in Dehong prefecture, Yunnan province, in 2011]. PCR
85  2011 An HIV-1 resistance polymorphism in TRIM5alpha gene among Chinese intravenous drug users. ---
86  2011 Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. HBV, HCV
87  2011 Difficulties with interferon treatment in former intravenous drug users. ---
88  2011 Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. IR, IRR, MSM, NR, NRR
89  2011 Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. RDS, SEP
90  2011 Migrant workers: a risk factor for HIV transmission. NACP
91  2011 Near full-length genomic characterization of a novel HIV type 1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China. ---
92  2011 Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan. HIV-1
93  2010 HIV type 1 genetic diversity in Silesia, Poland: a retrospective analysis. RT, STs
94  2010 Long terminal repeat sequence analysis of HTLV-2 molecular variants identified in Southern Brazil. HTLV-2, LTR, RFLP
95  2010 Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. ART, CI, HIV, HR, IDU, IQR
96  2010 Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006). HIV, HVI
97  2010 Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C. CHC, SVR
98  2010 Viral hepatitis B, C and HIV infection in Croatian prisons. ---
99  2010 [Causes of antiretroviral therapy discontinuation in the outpatient HIV/AIDS clinic in Lodz]. ARV
100  2010 [Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users]. ---